Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Hims & Hers
Marketing
NAD reaches split decision on Kenvue-Hims & Hers hair ad row
The NAD delivered a mixed verdict, telling Hims & Hers Health to change certain claims while dismissing other challenges brought by Kenvue.
Nick Paul Taylor
Aug 25, 2026 3:38am
Novo and Hims & Hers team up to sell branded GLP-1s, ending feud
Mar 9, 2026 11:55am
Novo's Wegovy spot tops pharma Super Bowl engagement rankings
Feb 9, 2026 5:00pm
Hims quits on obesity pill after legal, regulatory heat
Feb 9, 2026 10:24am
FDA commissioner pledges crackdown on compounding practices
Feb 6, 2026 9:59am
Fierce Healthcare
Hims & Hers plans to launch $49 copy of Wegovy pill
Feb 5, 2026 1:00pm